{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:44:37Z","timestamp":1791827077318,"version":"4.3.4"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","award":["101002571"],"award-info":[{"award-number":["101002571"]}],"id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["1S75019N"],"award-info":[{"award-number":["1S75019N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Research Foundation Flanders","doi-asserted-by":"publisher","award":["G039419N"],"award-info":[{"award-number":["G039419N"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Chemical Biology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.cbpa.2024.102531","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T16:06:35Z","timestamp":1728144395000},"page":"102531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Beyond chloroquine: Cationic amphiphilic drugs as endosomal escape enhancers for nucleic acid therapeutics"],"prefix":"10.1016","volume":"83","author":[{"given":"Aliona","family":"Debisschop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Bogaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Muntean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefaan C.","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9807-4715","authenticated-orcid":false,"given":"Koen","family":"Raemdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbpa.2024.102531_bib1","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.cbpa.2024.102531_bib2","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.cmet.2018.03.004","article-title":"RNA-targeted therapeutics","volume":"27","author":"Crooke","year":"2018","journal-title":"Cell Metabol"},{"key":"10.1016\/j.cbpa.2024.102531_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nantod.2018.06.007","article-title":"Methodologies to investigate intracellular barriers for nucleic acid delivery in non-viral gene therapy","volume":"21","author":"Vermeulen","year":"2018","journal-title":"Nano Today"},{"key":"10.1016\/j.cbpa.2024.102531_sref4","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114041","article-title":"Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics","volume":"181","author":"Van de Vyver","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cbpa.2024.102531_bib5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/pharmaceutics13030428","article-title":"Delivery systems for nucleic acids and proteins: barriers, cell capture pathways and nanocarriers","volume":"13","author":"Torres-Vanegas","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbpa.2024.102531_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1146\/annurev.biochem.78.081307.110540","article-title":"Mechanisms of endocytosis","volume":"78","author":"Doherty","year":"2009","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.cbpa.2024.102531_sref7","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2307800120","article-title":"Endosomal escape: a bottleneck for LNP-mediated therapeutics","volume":"121","author":"Chatterjee","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102531_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief update on endocytosis of nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cbpa.2024.102531_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9050512","article-title":"Chemical manipulation of the endosome trafficking machinery: implications for oligonucleotide delivery","volume":"9","author":"Juliano","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.cbpa.2024.102531_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1261\/rna.079507.122","article-title":"Endosomal escape of RNA therapeutics: how do we solve this rate-limiting problem?","volume":"29","author":"Dowdy","year":"2023","journal-title":"Rna"},{"key":"10.1016\/j.cbpa.2024.102531_bib11","article-title":"Exocytosis of nanoparticles: a comprehensive review","volume":"13","author":"Liu","year":"2023","journal-title":"Nanomaterials"},{"key":"10.1016\/j.cbpa.2024.102531_bib12","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nbt.2614","article-title":"Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling","volume":"31","author":"Sahay","year":"2013","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2024.102531_bib13","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1166\/jnn.2014.9082","article-title":"Endosomal escape: a bottleneck in intracellular delivery","volume":"14","author":"Shete","year":"2014","journal-title":"J\u00a0Nanosci Nanotechnol"},{"key":"10.1016\/j.cbpa.2024.102531_bib14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.biotechadv.2015.05.005","article-title":"A\u00a0role for peptides in overcoming endosomal entrapment in siRNA delivery - a focus on melittin","volume":"33","author":"Hou","year":"2015","journal-title":"Biotechnol Adv"},{"key":"10.1016\/j.cbpa.2024.102531_bib15","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1080\/17425247.2021.1873272","article-title":"Application of chloroquine as an endosomal escape enhancing agent: new frontiers for an old drug","volume":"18","author":"Hajimolaali","year":"2021","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.cbpa.2024.102531_bib16","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2533\/chimia.1997.34","article-title":"The proton sponge: a trick to enter cells the viruses did not exploit","volume":"51","author":"Behr","year":"1997","journal-title":"Chimia"},{"key":"10.1016\/j.cbpa.2024.102531_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10213","article-title":"Cytosolic delivery of nucleic acids: the case of ionizable lipid nanoparticles","volume":"6","author":"Schlich","year":"2021","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.cbpa.2024.102531_bib18","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1021\/acs.bioconjchem.3c00369","article-title":"Elucidating the impact of payload conjugation on the cell-penetrating efficiency of the endosomal escape peptide dfTAT: implications for future designs for CPP-based delivery systems","volume":"34","author":"Diaz","year":"2023","journal-title":"Bioconjugate Chem"},{"key":"10.1016\/j.cbpa.2024.102531_bib19","doi-asserted-by":"crossref","first-page":"12982","DOI":"10.1073\/pnas.0703778104","article-title":"Dynamic PolyConjugates for targeted in\u00a0vivo delivery of siRNA to hepatocytes","volume":"104","author":"Rozema","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cbpa.2024.102531_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jconrel.2010.04.012","article-title":"Prolonged gene silencing by combining siRNA nanogels and photochemical internalization","volume":"145","author":"Raemdonck","year":"2010","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.cbpa.2024.102531_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cocis.2021.101453","article-title":"Vapor nanobubble-mediated photoporation constitutes a versatile intracellular delivery technology","volume":"54","author":"Ramon","year":"2021","journal-title":"Curr Opin Colloid Interface Sci"},{"key":"10.1016\/j.cbpa.2024.102531_bib22","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000315101","article-title":"Functional Inhibitors of Acid Sphingomyelinase (FIASMAs): a novel pharmacological group of drugs with broad clinical applications","volume":"26","author":"Kornhuber","year":"2010","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.cbpa.2024.102531_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/978-3-7091-1368-4_9","article-title":"Functional inhibitors of acid sphingomyelinase (FIASMAs)","author":"Kornhuber","year":"2013","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.cbpa.2024.102531_bib24","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cmdc.201200306","article-title":"Identification of drugs inducing phospholipidosis by novel in\u00a0vitro data","volume":"7","author":"Muehlbacher","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.cbpa.2024.102531_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1126\/science.abi4708","article-title":"Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2","volume":"373","author":"Tummino","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.cbpa.2024.102531_bib26","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1042\/BST20140145","article-title":"Lysosomotropic agents: impact on lysosomal membrane permeabilization and cell death","volume":"42","author":"Villamil Giraldo","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.cbpa.2024.102531_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023852","article-title":"Identification of novel functional inhibitors of acid sphingomyelinase","volume":"6","author":"Kornhuber","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.cbpa.2024.102531_bib28","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1021\/acsnano.0c00666","article-title":"Cationic amphiphilic drugs boost the lysosomal escape of small nucleic acid therapeutics in a nanocarrier-dependent manner","volume":"14","author":"Van de Vyver","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.cbpa.2024.102531_bib29","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/0006-2952(74)90174-9","article-title":"Commentary. Lysosomotropic agents","volume":"23","author":"de Duve","year":"1974","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.cbpa.2024.102531_bib30","series-title":"The ADME encyclopedia: a comprehensive guide on biopharmacy and pharmacokinetics","first-page":"786","article-title":"pH partition theory","author":"Talevi","year":"2022"},{"key":"10.1016\/j.cbpa.2024.102531_bib31","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00249-008-0338-4","article-title":"Quantitative modeling of selective lysosomal targeting for drug design","volume":"37","author":"Trapp","year":"2008","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.cbpa.2024.102531_bib32","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/jm070524a","article-title":"Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model","volume":"51","author":"Kornhuber","year":"2008","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cbpa.2024.102531_bib33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2020.07.005","article-title":"The host targeting effect of chloroquine in malaria","volume":"66","author":"Coban","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.cbpa.2024.102531_bib34","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1021\/bi00527a031","article-title":"Liposome-mediated delivery of deoxyribonucleic acid to cells: enhanced efficiency of delivery related to lipid composition and incubation conditions","volume":"20","author":"Fraley","year":"1981","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbpa.2024.102531_bib35","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s11095-010-0245-0","article-title":"Enhanced gene and siRNA delivery by polycation-modified mesoporous silica nanoparticles loaded with chloroquine","volume":"27","author":"Bhattarai","year":"2010","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.cbpa.2024.102531_bib36","doi-asserted-by":"crossref","first-page":"6522","DOI":"10.1021\/jm060736s","article-title":"Structure-function correlation of chloroquine and analogues as transgene expression enhancers in nonviral gene delivery","volume":"49","author":"Cheng","year":"2006","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.cbpa.2024.102531_bib37","first-page":"1117","article-title":"Chloroquine enhances expression of lipofected ivt-mRNA","volume":"6","author":"Tusup","year":"2018","journal-title":"J\u00a0Pharmacol Clin Toxicol"},{"key":"10.1016\/j.cbpa.2024.102531_bib38","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.omtn.2023.07.019","article-title":"Chloroquine and cytosolic galectins affect endosomal escape of antisense oligonucleotides after Stabilin-mediated endocytosis","volume":"33","author":"Pandey","year":"2023","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.cbpa.2024.102531_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25020945","article-title":"Chloroquine and chemotherapeutic compounds in experimental cancer treatment","volume":"25","author":"Agalakova","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cbpa.2024.102531_bib40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/17425247.2020.1716729","article-title":"Chloroquine: a brand-new scenario for an old drug","volume":"17","author":"Baradaran","year":"2020","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.cbpa.2024.102531_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nantod.2017.06.012","article-title":"Small molecules convey big messages: boosting non-viral nucleic acid delivery with low molecular weight drugs","volume":"16","author":"Joris","year":"2017","journal-title":"Nano Today"},{"key":"10.1016\/j.cbpa.2024.102531_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41380-021-01309-5","article-title":"The acid sphingomyelinase\/ceramide system in COVID-19","volume":"27","author":"Kornhuber","year":"2022","journal-title":"Mol Psychiatr"},{"key":"10.1016\/j.cbpa.2024.102531_bib43","article-title":"Oxidative stress, proton fluxes, and chloroquine\/hydroxychloroquine treatment for COVID-19","volume":"9","author":"Klouda","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.cbpa.2024.102531_bib44","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1093\/oxfordjournals.jbchem.a135438","article-title":"Reduction of acid sphingomyelinase activity in human fibroblasts induced by AY-9944 and other cationic amphiphilic drugs","volume":"98","author":"Yoshida","year":"1985","journal-title":"J\u00a0Biochem"},{"key":"10.1016\/j.cbpa.2024.102531_bib45","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ccr.2013.08.003","article-title":"Transformation-associated changes in sphingolipid metabolism sensitize cells to lysosomal cell death induced by inhibitors of acid sphingomyelinase","volume":"24","author":"Petersen","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cbpa.2024.102531_bib46","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.virol.2015.04.022","article-title":"Ceramide formation mediated by acid sphingomyelinase facilitates endosomal escape of caliciviruses","volume":"483","author":"Shivanna","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.cbpa.2024.102531_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115412","article-title":"Chloroquine may induce endothelial injury through lysosomal dysfunction and oxidative stress","volume":"414","author":"Greg\u00f3rio","year":"2021","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.cbpa.2024.102531_bib48","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1242\/jcs.091181","article-title":"Lysosomal cell death at a glance","volume":"126","author":"Aits","year":"2013","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.cbpa.2024.102531_bib49","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jgm.340","article-title":"The in\u00a0vivo use of chloroquine to promote non-viral gene delivery to the liver via the portal vein and bile duct","volume":"5","author":"Zhang","year":"2003","journal-title":"J\u00a0Gene Med"},{"key":"10.1016\/j.cbpa.2024.102531_bib50","doi-asserted-by":"crossref","first-page":"7984","DOI":"10.1093\/nar\/gkv762","article-title":"Identification of siRNA delivery enhancers by a chemical library screen","volume":"43","author":"Gilleron","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2024.102531_bib51","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2017.11.019","article-title":"Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells","volume":"269","author":"Joris","year":"2018","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.cbpa.2024.102531_bib52","first-page":"195","volume":"13","author":"Berg","year":"2022"},{"key":"10.1016\/j.cbpa.2024.102531_bib53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ymgme.2016.12.008","article-title":"Types A and B niemann-pick disease","volume":"120","author":"Schuchman","year":"2017","journal-title":"Mol Genet Metabol"},{"key":"10.1016\/j.cbpa.2024.102531_sref54","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123348","article-title":"Repositioning the antihistamine ebastine as an intracellular siRNA delivery enhancer","volume":"644","author":"Muntean","year":"2023","journal-title":"Int J Pharm"},{"key":"10.1016\/j.cbpa.2024.102531_bib55","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/tra.12613","article-title":"Lysosomal membrane permeabilization and cell death","volume":"19","author":"Wang","year":"2018","journal-title":"Traffic"},{"key":"10.1016\/j.cbpa.2024.102531_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22179216","article-title":"Increasing angiogenesis factors in hypoxic diabetic wound conditions by siRNA delivery: additive effect of LbL-gold nanocarriers and desloratadine-induced lysosomal escape","volume":"22","author":"Shaabani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cbpa.2024.102531_sref57","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404784","article-title":"Multicompartment polyion complex micelles based on triblock polypept(o)ides mediate efficient siRNA delivery to cancer-associated fibroblasts for antistromal therapy of hepatocellular carcinoma","author":"Schneider","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.cbpa.2024.102531_bib58","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/s41467-020-15300-1","article-title":"Imaging small molecule-induced endosomal escape of siRNA","volume":"11","author":"Du","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.cbpa.2024.102531_bib59","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nbt.3298","article-title":"Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown","volume":"33","author":"Wittrup","year":"2015","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.cbpa.2024.102531_sref60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpb.2024.114223","article-title":"Evaluating \u03b22-agonists as siRNA delivery adjuvants for pulmonary surfactant-coated nanogel inhalation therapy","volume":"197","author":"Merckx","year":"2024","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.cbpa.2024.102531_sref61","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/nar\/gkad023","article-title":"Simultaneous inhibition of endocytic recycling and lysosomal fusion sensitizes cells and tissues to oligonucleotide therapeutics","volume":"51","author":"Finicle","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2024.102531_bib62","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1016\/j.ymthe.2019.07.018","article-title":"Endocytic profiling of cancer cell models reveals critical factors influencing LNP-mediated mRNA delivery and protein expression","volume":"27","author":"Sayers","year":"2019","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102531_bib63","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2023.10.014","article-title":"The alpha-adrenergic antagonist prazosin promotes cytosolic siRNA delivery from lysosomal compartments","volume":"364","author":"Van de Vyver","year":"2023","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.cbpa.2024.102531_bib64","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/nar\/gkv060","article-title":"High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides","volume":"43","author":"Yang","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.cbpa.2024.102531_sref65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s42003-022-03132-2","article-title":"Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides","volume":"5","author":"Bost","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/j.cbpa.2024.102531_bib66","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/mt.2016.179","article-title":"The niemann-pick C1 inhibitor NP3.47 enhances gene silencing potency of lipid nanoparticles containing siRNA","volume":"24","author":"Wang","year":"2016","journal-title":"Mol Ther"},{"key":"10.1016\/j.cbpa.2024.102531_bib67","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1021\/acschembio.7b00242","article-title":"A\u00a0novel family of small molecules that enhance the intracellular delivery and pharmacological effectiveness of antisense and splice switching oligonucleotides","volume":"12","author":"Wang","year":"2017","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.cbpa.2024.102531_bib68","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1021\/acschembio.9b00585","article-title":"Cytosolic delivery of macromolecules in live human cells using the combined endosomal escape activities of a small molecule and cell penetrating peptides","volume":"14","author":"Allen","year":"2019","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.cbpa.2024.102531_bib69","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1039\/C8SC04831B","article-title":"Lytic reactions of drugs with lipid membranes","volume":"10","author":"Britt","year":"2019","journal-title":"Chem Sci"},{"key":"10.1016\/j.cbpa.2024.102531_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz8598","article-title":"Lysis of membrane lipids promoted by small organic molecules: reactivity depends on structure but not lipophilicity","volume":"6","author":"Britt","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.cbpa.2024.102531_bib71","first-page":"2597","article-title":"Degradative transport of cationic amphiphilic drugs across phospholipid bilayers","volume":"364","author":"Baciu","year":"2006","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"10.1016\/j.cbpa.2024.102531_bib72","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2013.1062","article-title":"Amphiphilic drug interactions with model cellular membranes are influenced by lipid chain-melting temperature","volume":"11","author":"Casey","year":"2014","journal-title":"J\u00a0R Soc Interface"},{"key":"10.1016\/j.cbpa.2024.102531_bib73","article-title":"Cationic amphiphilic antihistamines inhibit STAT3 via Ca(2+)-dependent lysosomal H(+) efflux","volume":"42","author":"Liu","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.cbpa.2024.102531_sref74","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/112_2020_56","article-title":"Targeting cancer lysosomes with good old cationic amphiphilic drugs","volume":"185","author":"Ellegaard","year":"2023","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"10.1016\/j.cbpa.2024.102531_bib75","doi-asserted-by":"crossref","DOI":"10.3390\/cells11071156","article-title":"Amphiphilic cell-penetrating peptides containing natural and unnatural amino acids as drug delivery agents","volume":"11","author":"Salehi","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.cbpa.2024.102531_bib76","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1021\/acschembio.0c00319","article-title":"Impact of the endosomal escape activity of cell-penetrating peptides on the endocytic pathway","volume":"15","author":"Kondow-McConaghy","year":"2020","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.cbpa.2024.102531_bib77","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.addr.2018.04.015","article-title":"Sphingolipids as targets for inhalation treatment of cystic fibrosis","volume":"133","author":"Becker","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.cbpa.2024.102531_bib78","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.jconrel.2022.08.009","article-title":"A\u00a0lipid nanoparticle platform for mRNA delivery through repurposing of cationic amphiphilic drugs","volume":"350","author":"Bogaert","year":"2022","journal-title":"J\u00a0Contr Release"},{"key":"10.1016\/j.cbpa.2024.102531_sref79","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/acs.nanolett.3c03345","article-title":"Selective replacement of cholesterol with cationic amphiphilic drugs enables the design of lipid nanoparticles with improved RNA delivery","volume":"24","author":"Bogaert","year":"2024","journal-title":"Nano Lett"},{"key":"10.1016\/j.cbpa.2024.102531_bib80","first-page":"161","article-title":"Interactions between tricyclic antidepressants and phospholipid bilayer membranes","volume":"24","author":"Fisar","year":"2005","journal-title":"Gen Physiol Biophys"}],"container-title":["Current Opinion in Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593124001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1367593124001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T13:06:40Z","timestamp":1732367200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1367593124001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":80,"alternative-id":["S1367593124001078"],"URL":"https:\/\/doi.org\/10.1016\/j.cbpa.2024.102531","relation":{},"ISSN":["1367-5931"],"issn-type":[{"value":"1367-5931","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond chloroquine: Cationic amphiphilic drugs as endosomal escape enhancers for nucleic acid therapeutics","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Chemical Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbpa.2024.102531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102531"}}